InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,700
-350 (-1.16%)
Apr 28, 2026, 3:30 PM KST
26.11%
Market Cap 396.14B
Revenue (ttm) 233.95B
Net Income (ttm) 30.63B
Shares Out 13.34M
EPS (ttm) 2,422.95
PE Ratio 12.26
Forward PE 10.04
Dividend 400.00 (1.33%)
Ex-Dividend Date Mar 30, 2026
Volume 9,233
Average Volume 39,221
Open 30,200
Previous Close 30,050
Day's Range 29,500 - 30,200
52-Week Range 22,850 - 36,000
Beta 0.48
RSI 51.14
Earnings Date May 12, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2025, InBody Co.,Ltd's revenue was 233.95 billion, an increase of 14.42% compared to the previous year's 204.46 billion. Earnings were 30.63 billion, a decrease of -7.57%.

Financial Statements

News

There is no news available yet.